Raymond James Trust N.A. Purchases 1,113 Shares of iShares Biotechnology ETF (NASDAQ:IBB)

Raymond James Trust N.A. raised its position in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 71.5% in the third quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 2,669 shares of the financial services provider’s stock after purchasing an additional 1,113 shares during the quarter. Raymond James Trust N.A.’s holdings in iShares Biotechnology ETF were worth $389,000 at the end of the most recent quarter.

Several other large investors have also bought and sold shares of the company. Blue Fin Capital Inc. increased its position in shares of iShares Biotechnology ETF by 0.7% during the second quarter. Blue Fin Capital Inc. now owns 10,516 shares of the financial services provider’s stock valued at $1,443,000 after acquiring an additional 74 shares in the last quarter. Security National Bank of SO Dak boosted its stake in iShares Biotechnology ETF by 0.7% during the 2nd quarter. Security National Bank of SO Dak now owns 10,461 shares of the financial services provider’s stock valued at $1,436,000 after purchasing an additional 75 shares during the last quarter. SPC Financial Inc. increased its holdings in shares of iShares Biotechnology ETF by 2.4% in the 3rd quarter. SPC Financial Inc. now owns 3,265 shares of the financial services provider’s stock worth $475,000 after purchasing an additional 75 shares in the last quarter. Werba Rubin Papier Wealth Management raised its stake in shares of iShares Biotechnology ETF by 2.7% in the third quarter. Werba Rubin Papier Wealth Management now owns 2,918 shares of the financial services provider’s stock worth $425,000 after purchasing an additional 76 shares during the last quarter. Finally, Main Street Financial Solutions LLC lifted its holdings in shares of iShares Biotechnology ETF by 1.0% during the second quarter. Main Street Financial Solutions LLC now owns 8,002 shares of the financial services provider’s stock valued at $1,098,000 after purchasing an additional 82 shares in the last quarter. 62.45% of the stock is owned by hedge funds and other institutional investors.

iShares Biotechnology ETF Stock Up 0.2 %

iShares Biotechnology ETF stock opened at $140.23 on Wednesday. iShares Biotechnology ETF has a one year low of $117.28 and a one year high of $150.57. The business’s fifty day moving average is $143.27 and its 200 day moving average is $141.92.

iShares Biotechnology ETF Dividend Announcement

The business also recently declared a dividend, which was paid on Monday, September 30th. Stockholders of record on Wednesday, September 25th were paid a $0.2005 dividend. The ex-dividend date of this dividend was Wednesday, September 25th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.